TS Financial Group (TSFG)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

TS Financial Group (TSFG)’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$24K	–	1090
2023 Q1	$24K	Hold	1,000	–	–	0.01%	384
2022 Q4	$11K	Hold	1,000	–	–	﹤0.01%	527
2022 Q3	$5K	Hold	1,000	–	–	﹤0.01%	657
2022 Q2	$4K	Hold	1,000	–	–	﹤0.01%	697
2022 Q1	$7K	Hold	1,000	–	–	﹤0.01%	608
2021 Q4	$6K	Hold	1,000	–	–	﹤0.01%	655
2021 Q3	$6K	Hold	1,000	–	–	﹤0.01%	640
2021 Q2	$8K	Hold	1,000	–	–	﹤0.01%	599
2021 Q1	$10K	Hold	1,000	–	–	0.01%	500
2020 Q4	$17K	Buy	+1,000	New	+$15K	0.01%	400

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

TS Financial Group (TSFG)'s PRVB Position: Q2 2023 in Review

TS Financial Group (TSFG) sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,000 shares — an estimated $24K sold.

TS Financial Group (TSFG) first reported a position in PRVB in Q4 2020 and held it in 10 quarters. The position peaked at $24K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

TS Financial Group (TSFG) reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
TS Financial Group (TSFG) sold 1,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $24K.
TS Financial Group (TSFG) first reported a position in Provention Bio, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
TS Financial Group (TSFG)'s Provention Bio, Inc. Common Stock position peaked at $24K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2023, filed 10 Jul 2023.